Skip to main content

Table 2 Predictors of prolonged LOS using multivariate logistic regression

From: Exploring the impact of intravenous thrombolysis on length of stay for acute ischemic stroke: a retrospective cohort study

 

OR (95 % CI), all patients, n = 3054

P value

OR (95 % CI), hospital survivors, n = 2963

P value

Age

1.01 (1.00–1.02)

0.019

1.01 (1.00–1.02)

0.019

NIHSS at admission

    

  ≤ 5

Reference

 

Reference

 

 6–10

2.75 (2.28–3.33)

< 0.001

2.83 (2.34–3.43)

< 0.001

 11–15

8.01 (5.67–11.31)

< 0.001

8.32 (5.86–11.83)

< 0.001

 16–20

9.65 (6.32–14.74)

< 0.001

11.07(7.06–17.36)

< 0.001

  > 20

7.62 (5.48–10.60)

< 0.001

19.15 (12.01–30.53)

< 0.001

Diabetes mellitus

1.30 (1.10–1.53)

0.002

1.34 (1.13–1.58)

0.001

Leukocytosis (> 10 × 109 cells/L) at admission

1.46 (1.19–1.80)

< 0.001

1.55 (1.25–1.92)

< 0.001

Intravenous thrombolysis

0.53 (0.38–0.74)

< 0.001

0.49 (0.34–0.71)

< 0.001

  1. CI confidence interval, LOS length of stay, NIHSS National Institutes of Health Stroke Scale, OR odds ratio